Immix Biopharma, Inc. 4

No insider trades are reported; this filing only grants power of attorney to file Section 16 reports for Nancy T. Chang.

The document provided is not a Form 4 reporting an insider transaction, but rather a Limited Power of Attorney executed by Nancy T. Chang on May 26, 2026, authorizing certain individuals at Immix Biopharma, Inc. to prepare, sign, and file Section 16 ownership reports (Forms 3, 4, and 5) on her behalf. It does not disclose any actual purchases, sales, grants, or other changes in beneficial ownership of the company’s securities, and therefore no transaction amounts, prices, or post-transaction holdings can be inferred from this filing alone.

Filing Facts

CIK

1873835

Ticker

IMMX

Form

4

Source Type

sec

Accession

0001493152-26-026426

Alert Tier

4